Levoleucovorin (Amneal Biosciences)


Welcome to the PulseAid listing for the Levoleucovorin drug offered from Amneal Biosciences. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amneal Biosciences
NON-PROPRIETARY NAME: Levoleucovorin
SUBSTANCE NAME: LEVOLEUCOVORIN CALCIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-02-13
END MARKETING DATE: 0000-00-00


Levoleucovorin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevoleucovorin from Amneal Biosciences
LABELER NAME: Amneal Biosciences
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2017-02-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70121-1099_ec496297-5657-4dd1-a9fe-7044365eb6b5
PRODUCT NDC: 70121-1099
APPLICATION NUMBER: ANDA207547

Other LEVOLEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.levoleucovorin
Amneal BiosciencesLevoleucovorin
Mylan Institutional LLCLEVOLEUCOVORIN CALCIUM
Spectrum Pharmaceuticals, Inc.Fusilev
West-Ward Pharmaceuticals CorpLevoleucovorin